| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amiodarone for the Restoration of Sinus Rhythm in Patients with Atrial Fibrillation
|
Panos E. Vardas
|
|
2003
|
7 |
3 |
p. 297-299
3 p.
|
artikel
|
| 2 |
Amiodarone for the Restoration of Sinus Rhythm in Patients with Atrial Fibrillation
|
Vardas, Panos E.
|
|
2003
|
7 |
3 |
p. 297-299
|
artikel
|
| 3 |
Angiotensin Receptor Blocker as Adjunctive Therapy for Rhythm Control in Atrial Fibrillation Results of the Irbesartan-Amiodarone Trial
|
Antonio H. Madrid
|
|
2003
|
7 |
3 |
p. 243-246
4 p.
|
artikel
|
| 4 |
Angiotensin Receptor Blocker as Adjunctive Therapy for Rhythm Control in Atrial Fibrillation: Results of the Irbesartan-Amiodarone Trial
|
Madrid, Antonio H.
|
|
2003
|
7 |
3 |
p. 243-246
|
artikel
|
| 5 |
Antiarrhythmic Surgery to Cure Atrial FibrillationSubgroups and Postoperative Management
|
Thomas Deneke
|
|
2003
|
7 |
3 |
p. 259-263
5 p.
|
artikel
|
| 6 |
Antiarrhythmic Surgery to Cure Atrial Fibrillation—Subgroups and Postoperative Management
|
Deneke, Thomas
|
|
2003
|
7 |
3 |
p. 259-263
|
artikel
|
| 7 |
An Update on Electrical Cardioversion of Atrial Fibrillation
|
Suneet Mittal
|
|
2003
|
7 |
3 |
p. 285-289
5 p.
|
artikel
|
| 8 |
An Update on Electrical Cardioversion of Atrial Fibrillation
|
Mittal, Suneet
|
|
2003
|
7 |
3 |
p. 285-289
|
artikel
|
| 9 |
Azimilide for Atrial Fibrillation Clinical Trial Results and Implications
|
Edward L.C. Pritchett
|
|
2003
|
7 |
3 |
p. 215-219
5 p.
|
artikel
|
| 10 |
Azimilide for Atrial Fibrillation: Clinical Trial Results and Implications
|
Pritchett, Edward L.C.
|
|
2003
|
7 |
3 |
p. 215-219
|
artikel
|
| 11 |
Beta-Blocker Efficacy According to Heart Rate and Rhythm in Patients with Heart Failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II Analysis
|
Philippe P. Lechat
|
|
2003
|
7 |
3 |
p. 233-235
3 p.
|
artikel
|
| 12 |
Beta-Blocker Efficacy According to Heart Rate and Rhythm in Patients with Heart Failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II Analysis
|
Lechat, Philippe P.
|
|
2003
|
7 |
3 |
p. 233-235
|
artikel
|
| 13 |
Beta Blockers Improve Outcome in Patients with Heart Failure and Atrial Fibrillation U.S. Carvedilol Study
|
Karthik Ramaswamy
|
|
2003
|
7 |
3 |
p. 229-232
4 p.
|
artikel
|
| 14 |
Beta Blockers Improve Outcome in Patients with Heart Failure and Atrial Fibrillation: U.S. Carvedilol Study
|
Ramaswamy, Karthik
|
|
2003
|
7 |
3 |
p. 229-232
|
artikel
|
| 15 |
Biphasic Versus Monophasic Shock Waveform for Conversion of Atrial Fibrillation
|
Robert W. Rho
|
|
2003
|
7 |
3 |
p. 290-291
2 p.
|
artikel
|
| 16 |
Biphasic Versus Monophasic Shock Waveform for Conversion of Atrial Fibrillation
|
Rho, Robert W.
|
|
2003
|
7 |
3 |
p. 290-291
|
artikel
|
| 17 |
Conducting Randomized Trials in the Electrophysiology Laboratory Lessons from a Randomized Comparison of Recording Methods During Pulmonary Vein Isolation by Segmental Ostial Ablation
|
Hakan Oral
|
|
2003
|
7 |
3 |
p. 247-251
5 p.
|
artikel
|
| 18 |
Conducting Randomized Trials in the Electrophysiology Laboratory: Lessons from a Randomized Comparison of Recording Methods During Pulmonary Vein Isolation by Segmental Ostial Ablation
|
Oral, Hakan
|
|
2003
|
7 |
3 |
p. 247-251
|
artikel
|
| 19 |
Cost Evaluation of Rhythm Control Methods for Atrial Fibrillation Evidence from CTAF
|
Stanley Nattel
|
|
2003
|
7 |
3 |
p. 211-214
4 p.
|
artikel
|
| 20 |
Cost Evaluation of Rhythm Control Methods for Atrial Fibrillation: Evidence from CTAF
|
Nattel, Stanley
|
|
2003
|
7 |
3 |
p. 211-214
|
artikel
|
| 21 |
Does Conversion and Prevention of Atrial Fibrillation Enhance Survival in Patients with Left Ventricular Dysfunction Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) Study
|
Ole Dyg Pedersen
|
|
2003
|
7 |
3 |
p. 220-224
5 p.
|
artikel
|
| 22 |
Does Conversion and Prevention of Atrial Fibrillation Enhance Survival in Patients with Left Ventricular Dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) Study
|
Pedersen, Ole Dyg
|
|
2003
|
7 |
3 |
p. 220-224
|
artikel
|
| 23 |
Effect of Electrode Position on the Outcome of Cardioversion
|
Paulus Kirchhof
|
|
2003
|
7 |
3 |
p. 292-296
5 p.
|
artikel
|
| 24 |
Effect of Electrode Position on the Outcome of Cardioversion
|
Kirchhof, Paulus
|
|
2003
|
7 |
3 |
p. 292-296
|
artikel
|
| 25 |
Facilitating Electrical Cardioversion of Persistant Atrial Fibrillation by Antiarrhythmic Drugs Update on Clinical Trial Results
|
Ruey J. Sung
|
|
2003
|
7 |
3 |
p. 300-303
4 p.
|
artikel
|
| 26 |
Facilitating Electrical Cardioversion of Persistant Atrial Fibrillation by Antiarrhythmic Drugs: Update on Clinical Trial Results
|
Sung, Ruey J.
|
|
2003
|
7 |
3 |
p. 300-303
|
artikel
|
| 27 |
How Should Subgroup Analyses Affect Clinical Practice Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
|
John Wikstrand
|
|
2003
|
7 |
3 |
p. 264-275
12 p.
|
artikel
|
| 28 |
How Should Subgroup Analyses Affect Clinical Practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
|
Wikstrand, John
|
|
2003
|
7 |
3 |
p. 264-275
|
artikel
|
| 29 |
Left Versus Bi-Atrial Intraoperative Saline-Irrigated Radiofrequency Modified Maze Procedure for Atrial Fibrillation
|
Mustafa Guden
|
|
2003
|
7 |
3 |
p. 252-258
7 p.
|
artikel
|
| 30 |
Left Versus Bi-Atrial Intraoperative Saline-Irrigated Radiofrequency Modified Maze Procedure for Atrial Fibrillation
|
Guden, Mustafa
|
|
2003
|
7 |
3 |
p. 252-258
|
artikel
|
| 31 |
Quality of Life Variables in the Selection of Rate Versus Rhythm Control in Patients with Atrial Fibrillation Observations from the Canadian Trial of Atrial Fibrillation
|
Paul Dorian
|
|
2003
|
7 |
3 |
p. 276-279
4 p.
|
artikel
|
| 32 |
Quality of Life Variables in the Selection of Rate Versus Rhythm Control in Patients with Atrial Fibrillation: Observations from the Canadian Trial of Atrial Fibrillation
|
Dorian, Paul
|
|
2003
|
7 |
3 |
p. 276-279
|
artikel
|
| 33 |
Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial
|
Denis Roy
|
|
2003
|
7 |
3 |
p. 208-210
3 p.
|
artikel
|
| 34 |
Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial
|
Roy, Denis
|
|
2003
|
7 |
3 |
p. 208-210
|
artikel
|
| 35 |
Role of Beta-Blocker Therapy in Heart Failure and Atrial Fibrillation
|
Jeffrey W.H. Fung
|
|
2003
|
7 |
3 |
p. 236-242
7 p.
|
artikel
|
| 36 |
Role of Beta-Blocker Therapy in Heart Failure and Atrial Fibrillation
|
Fung, Jeffrey W.H.
|
|
2003
|
7 |
3 |
p. 236-242
|
artikel
|
| 37 |
Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
|
Steven N. Singh
|
|
2003
|
7 |
3 |
p. 225-228
4 p.
|
artikel
|
| 38 |
Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
|
Singh, Steven N.
|
|
2003
|
7 |
3 |
p. 225-228
|
artikel
|
| 39 |
Significance of Atrial Fibrillation During Acute Myocardial Infarction, and its Current Management Insights from the GUSTO-3 Trial
|
Cheuk-Kit Wong
|
|
2003
|
7 |
3 |
p. 201-207
7 p.
|
artikel
|
| 40 |
Significance of Atrial Fibrillation During Acute Myocardial Infarction, and its Current Management: Insights from the GUSTO-3 Trial
|
Wong, Cheuk-Kit
|
|
2003
|
7 |
3 |
p. 201-207
|
artikel
|
| 41 |
Time to First Recurrence as a Trial Endpoint Time to Change
|
Rahul Mehra
|
|
2003
|
7 |
3 |
p. 280-284
5 p.
|
artikel
|
| 42 |
Time to First Recurrence as a Trial Endpoint: Time to Change?
|
Mehra, Rahul
|
|
2003
|
7 |
3 |
p. 280-284
|
artikel
|
Tijdschrift beschrijving